Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Treasury Shares (2019 - 2025)

AVITA Medical's Treasury Shares history spans 7 years, with the latest figure at $67048.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 42.79% year-over-year to $67048.0; the TTM value through Dec 2025 reached $67048.0, down 42.79%, while the annual FY2025 figure was $67048.0, 42.79% down from the prior year.
  • Treasury Shares reached $67048.0 in Q4 2025 per RCEL's latest filing, roughly flat from $67048.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $461496.0 in Q3 2022 to a low of $67048.0 in Q3 2025.
  • Average Treasury Shares over 5 years is $220079.2, with a median of $214269.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: plummeted 70.53% in 2021, then skyrocketed 190.69% in 2022.
  • A 5-year view of Treasury Shares shows it stood at $297490.0 in 2021, then surged by 54.8% to $460518.0 in 2022, then plummeted by 48.94% to $235132.0 in 2023, then crashed by 50.16% to $117196.0 in 2024, then crashed by 42.79% to $67048.0 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Treasury Shares are $67048.0 (Q4 2025), $67048.0 (Q3 2025), and $99504.0 (Q2 2025).